M2i Global, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that M2i Global, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Nov 30, 2023 | $3.4K | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | $1.0K | Apr 16, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Nov 30, 2022 | $1.0K | Mar 15, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($6.49M) | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | ($3.89M) | Jan 28, 2026 |
| FY2024 | Nov 30, 2023 | ($1.99M) | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | ($66.4K) | Apr 16, 2024 |
| FY2022 | Nov 30, 2021 | $17.8K | Mar 15, 2023 |
| FY2021 | Nov 30, 2020 | ($19.2K) | Feb 28, 2022 |
| FY2019 | Nov 30, 2019 | ($15.4K) | Feb 28, 2020 |
| FY2019 | Nov 30, 2018 | ($4.9K) | Feb 28, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($5.97M) | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | ($3.80M) | Jan 28, 2026 |
| FY2024 | Nov 30, 2023 | ($1.98M) | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | ($66.4K) | Apr 16, 2024 |
| FY2020 | Nov 30, 2020 | $39.5K | Feb 2, 2021 |
| FY2020 | Nov 30, 2019 | $20.3K | Feb 2, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($4.24M) | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | ($2.10M) | Jan 28, 2026 |
| FY2024 | Nov 30, 2023 | ($1.61M) | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | ($13.0K) | Apr 16, 2024 |
| FY2022 | Nov 30, 2021 | $35.2K | Mar 15, 2023 |
| FY2020 | Nov 30, 2020 | ($19.6K) | Feb 2, 2021 |
| FY2020 | Nov 30, 2019 | ($15.4K) | Feb 2, 2021 |
| FY2019 | Nov 30, 2018 | ($4.9K) | Feb 28, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $488.0K | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | $85.4K | Jan 28, 2026 |
| FY2024 | Nov 30, 2023 | $48.2K | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | $125.9K | Apr 16, 2024 |
| FY2022 | Nov 30, 2021 | $19.5K | Mar 15, 2023 |
| FY2021 | Nov 30, 2020 | $11.7K | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $391 | Feb 2, 2021 |
| FY2019 | Nov 30, 2018 | $7.1K | Feb 28, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $7.54M | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | $2.62M | Jan 28, 2026 |
| FY2024 | Nov 30, 2023 | $1.09M | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | $122.3K | Apr 16, 2024 |
| FY2022 | Nov 30, 2021 | $40.0K | Mar 15, 2023 |
| FY2021 | Nov 30, 2020 | $27.5K | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | ($16.3K) | Feb 2, 2021 |
| FY2019 | Nov 30, 2018 | $7.1K | Feb 28, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($7.05M) | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | ($2.53M) | Jan 28, 2026 |
| FY2025 | Nov 30, 2023 | ($1.04M) | Jan 28, 2026 |
| FY2024 | Nov 30, 2022 | $3.6K | Feb 27, 2025 |
| FY2023 | Nov 30, 2021 | ($20.6K) | Apr 16, 2024 |
| FY2022 | Nov 30, 2020 | ($15.9K) | Mar 15, 2023 |
| FY2021 | Nov 30, 2019 | ($16.3K) | Feb 28, 2022 |
| FY2019 | Nov 30, 2018 | ($900) | Feb 28, 2020 |
| FY2019 | Jun 12, 2018 | $0 | Feb 28, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($12.49M) | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | ($6.00M) | Jan 28, 2026 |
| FY2024 | Nov 30, 2023 | ($2.11M) | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | ($123.8K) | Apr 16, 2024 |
| FY2022 | Nov 30, 2021 | $57.3K | Mar 15, 2023 |
| FY2021 | Nov 30, 2020 | $39.5K | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | ($20.3K) | Feb 2, 2021 |
| FY2019 | Nov 30, 2018 | ($4.9K) | Feb 28, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Nov 30, 2022 | $114 | Mar 15, 2023 |
| FY2022 | Nov 30, 2021 | $114 | Mar 15, 2023 |
| FY2021 | Nov 30, 2020 | $11.3K | Feb 28, 2022 |
| FY2020 | Nov 30, 2019 | $391 | Feb 2, 2021 |
| FY2019 | Nov 30, 2018 | $5.2K | Feb 28, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Jan 28, 2026 |
| FY2024 | Nov 30, 2023 | 0 | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Nov 30, 2021 | 0 | Mar 15, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Jan 28, 2026 |
| FY2023 | Nov 30, 2023 | 0 | Apr 16, 2024 |
| FY2023 | Nov 30, 2022 | 0 | Apr 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 712.65M | Jan 28, 2026 |
| FY2025 | Nov 30, 2024 | 581.70M | Jan 28, 2026 |
| FY2024 | Nov 30, 2023 | 514.33M | Feb 27, 2025 |
| FY2023 | Nov 30, 2022 | 7.11M | Apr 16, 2024 |
| FY2022 | Nov 30, 2021 | 5.09M | Mar 15, 2023 |
| FY2021 | Nov 30, 2020 | 4.65M | Feb 28, 2022 |
| FY2021 | Nov 30, 2019 | 4.00M | Feb 28, 2022 |
| FY2019 | Nov 30, 2018 | 4.00M | Feb 28, 2020 |